ctp-656
Small moleculeexperimental
Clinical trial activity
7 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
5
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2015 (NCT02599792)
Timeline
Indications
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ctp-656
- ctp-656
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03912233 | Phase 2 | Apr 30, 2019 | Vertex |
| NCT03911713 | Phase 2 | Apr 17, 2019 | Vertex |
| NCT03224351 | Phase 2 | Aug 8, 2017 | Vertex |
| NCT03227471 | Phase 1/Phase 2 (Phase 2) | Jan 23, 2017 | Vertex |
| NCT02971839 | Phase 2 | Dec 1, 2016 | Concert Pharmaceuticals |
| NCT02680249 | Phase 1 | Feb 1, 2016 | Concert Pharmaceuticals |
| NCT02599792 | Phase 1 | Nov 1, 2015 | Concert Pharmaceuticals |
Showing 7 of 7 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Vertex | For profit | 4 | 4 | 1 | 2017 |
| Concert Pharmaceuticals | For profit | 3 | 3 | 2 | 2015 |
2 organizations
Page 1 / 1